An observational study in Head and Neck Cancer, sponsored by Alberta Health services. Completed at 1 site in Canada. Per ClinicalTrials.gov, last updated 2013-01-28.
Sponsored by Alberta Health services · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 202 studies in Head and Neck Neoplasms with a site in Canada — 32 open to participants now, 56 under way, 11 of them phase 3. Head and Neck Neoplasms · Canada.
Among the 202 studies in Head and Neck Neoplasms with a site in Canada, this one is the 13th largest by planned enrollment of the 24 observational ones that give a count, is one of 9 that started in 2006, is one of 24 observational ones, and was the 36th registered.
2,718 studies on the registry are indexed under Head and Neck Neoplasms; 599 are open to participants now.
Browse Head and Neck Neoplasms studies →32 of the 202 studies in Head and Neck Neoplasms with a site in Canada are open now. Recruiting first, the newest first:
University Health Network, Toronto · Sites in Canada
Ages 18+
Pfizer · Sites in Canada, United States, China and 3 more countries
Ages 18+
Western University, Canada · Sites in Canada
Ages 18+
Canadian Cancer Trials Group · Sites in Canada
Ages 18+
University of Alberta · Sites in Canada
Ages 18+
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 458 Head and Neck Neoplasms studies recruiting now, 350 (76%) set no upper age limit and 51 (11%) stop at 75 or younger; 22 take children under 18; 27 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
202 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 36 · Phase 2 70 · Phase 3 44 · Phase 4 1
First in 1994; this study’s year is marked. 9 started in 2006.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 100 is close to the median of 100 across 506 observational studies indexed under Head and Neck Neoplasms.
Median enrollment 70 across the 170 interventional studies, 135 across the 24 observational. Of the 131 that completed or were terminated, 37 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
69 of 202 have an industry lead sponsor. The 10 most frequent:
Alberta Health services is the lead sponsor of 40 studies on the registry; 3 are open to participants now.
Alberta Health services has 3 studies filed under Head and Neck Neoplasms — fewer than ten, so there is no comparison to draw.
13 of the studies in Head and Neck Neoplasms with a site in Canada that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT03759431Centre hospitalier de l'Université de Montréal (CHUM)Vocal-cord vs. Complete Laryngeal Radiotherapy for Early Glottic Cancer | 2026-12-12 |
| NCT04671862Ottawa Hospital Research InstitutePhotobiomodulation for the Prevention of Radiation Induced Oral Mucositis | 2026-12-31 |
| NCT06578871London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sSurgery and Reducing Ionizing Radiation of the Unknown Primary | 2026-12-31 |
| NCT06192771University Health Network, TorontoFeasibility of Early Swallowing and Speech Intervention for Head and Neck Cancer Patients Treated SURGically | 2026-12-31 |
| NCT05941507LigaChem Biosciences, Inc.A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors | 2027-01 |
Add all 13 to your calendar (.ics) → With an account.
Among the 202 studies in Head and Neck Neoplasms with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
To describe the charactersitics of patients with advanced head and neck cancer treated with palliative intent and determine outcome in terms of symptom control and toxicity
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The record gives a start of Jan 2006 and a completion of Jun 2006. It does not say whether these dates are actual or estimated.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jul 2006. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Alberta Health services